Infection with Plasmodium falciparum during pregnancy leads to the accumulation of parasite-infected erythrocytes in the placenta 1 , and is associated with excess perinatal mortality, premature delivery and intrauterine growth retardation in the infant, as well as increased maternal mortality and morbidity 2, 3 . P. falciparum can adhere to specific receptors on host cells, an important virulence factor enabling parasites to accumulate in various organs 4 . We report here that most P. falciparum isolates from infected placentae can bind to hyaluronic acid, a newly discovered receptor for parasite adhesion that is present on the placental lining. In laboratory isolates selected for specific high-level adhesion, binding to hyaluronic acid could be inhibited by dodecamer or larger oligosaccharide fragments or polysaccharides, treatment of immobilized receptor with hyaluronidase, or treatment of infected erythrocytes with trypsin. In vitro flow-based assays demonstrated that high levels of adhesion occurred at low wall shear stress, conditions thought to prevail in the placenta. Our findings indicate that adhesion to hyaluronic acid is involved in mediating placental parasite accumulation, thus changing the present understanding of the mechanisms of placental infection, with implications for the development of therapeutic and preventative interventions.
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Syncytiotrophoblasts lining the intervillous spaces constitute an extensive area of fetal tissue in contact with the maternal circulation. Hyaluronic acid (or hyaluronan; HA) is prominent on the surface of this layer and may help protect against graft rejection, in combination with other mechanisms, by masking fetal antigens from the maternal immune system [5] [6] [7] . HA is a high-molecular-weight (up to several million daltons) glycosaminoglycan, consisting of repeating disaccharide units formed by N-acetylglucosamine and glucuronic acid, and differs from other glycosaminoglycans by its lack sulfation 8 . Adhesion to chondroitin sulfate A (CSA), which is also present on the placental lining, may be involved in placental infection 9, 10 . We tested placental isolates directly for adhesion to immobilized, purified HA (Table  1) , and compared these results with the adhesive characteristics of isolates from the peripheral blood of pregnant women and children (Fig. 1a) . Twelve of fifteen (80%) placental isolates demonstrated substantial adhesion to HA, whereas only five of fourteen (36%) peripheral maternal isolates, and five of fifteen (33%) peripheral isolates from children did so. The level of binding of placental isolates to HA was much higher than to CD36 (178 ± 403 and 9.9 ± 23.5 infected erythrocytes (IEs) bound/mm 2 , respectively (mean ± s.d.); P < 0.01, Mann-Whitney U test; Fig. 1b ) and was similar to binding to CSA (188 ± 351 IEs bound/mm 2 ). Only three of fourteen (21.4%) placental isolates bound in substantial amounts to CD36 (Fig. 1a) , which has not been detected on syncytiotrophoblasts, and these did so only at low levels. However, most isolates (ten of fourteen; 71%) from children bound CD36 at much higher levels than binding of the same iso- HA  CSA  CD36  ICAM-1   Placental isolates  A  5 3  0  0  N A  B  1  1 3  0  N A  C  23  933  0  0  D  1 1  5 9  0  0  E  103  386  NA  NA  F  3 8  3 1  2 5  0  G  1,254  17  18  0  H  3  0  1  0  I  3 3  1 3  0  0  J  1,075  64  1  0  K  13  140  0  0  L  34  1,100  87  0  M  1 0  1 9  4  1  N  0  4 0  1  1  O  1 1  6  2  0  Laboratory isolates  CS2  1,475  2,146  17  15  E8B  12  29  538  330  E8B-HAsel3  1,527  1,963  12  1  3D7  30  35  663  1  3D7-HAsel3  817  518  72  0 Data represent mean number of bound IEs/mm 2 above that recorded for bovine serum albumin controls (mean of triplicate spots; s.d. excluded for clarity). NA, not assessed. Fig. 1 Receptor-specific adhesion of P. falciparum isolates. a, The proportion of isolates collected from the placenta (n = 15), peripheral blood of pregnant women (maternal; n = 14) and peripheral blood of children (n = 15) that bound to immobilized purified HA (í), CSA (२) and/or CD36 (hatched bars) at a level of ≥ (Table 1) in addition to CSA, but there was little or no adhesion to CD36 or ICAM-1. As for the clinical samples, adhesion to HA was isolatespecific and not a feature of all IEs. Parasite isolates E8B, the parent of CS2, and 3D7 bound only at low levels to immobilized HA (Table 1 ). E8B and 3D7 were separately passaged through three cycles of selection for adhesion to HA, thereby modeling a process thought to occur in vivo, to yield E8B-HAsel3 and 3D7-HAsel3 (Table 1) . For each, adhesion to both HA and CSA increased considerably, indicating these isolates co-express ligands for the two receptors, with a corresponding reduction in adhesion to CD36 and ICAM-1 (Table 1) .
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Confirming the specificity of the interaction with HA, there was no adhesion of the isolates to heparin/heparan sulfate or colominic acid (a sialic acid polymer that, like HA, carries charge through carboxylic acid groups and not sulfate groups), nor was there adhesion to a variety of other purified glycosaminoglycans and polysulfated sugars. Adhesion was maximal at physiologic pH of 7.2-7.6, and there was no adhesion of uninfected erythrocytes. Treatment of immobilized HA with hyaluronidase (which also digests chondroitin sulfates) before assessment of IE adhesion completely abolished binding, whereas there was no effect with heparinase ( Fig. 2a) . We used chondroitinase ABC (which digests chondroitin sulfates and, at a slower rate, HA) to treat immobilized receptors, to demonstrate a selective reduction of adhesion to immobilized CSA compared with adhesion to HA (Fig.  2a) , supporting a specific interaction of IEs with HA.
Adhesion of CS2 IEs to immobilized HA was inhibited in a concentration-dependent manner by soluble HA (Fig. 2b) ; at a concentration of 0.4 µM, inhibition was 85.1 ± 1.9% (mean ± s.e.m.). There was no substantial inhibition of adhesion to HA with 0.4 µM soluble colominic acid (10 ± 10.5% inhibition), but there was some inhibition with 0.4 µM CSA and 0.4 µM chondroitin sulfate C (63.5 ± 6.3% and 27.1 ± 8.9%, respectively), which are sulfated and more highly charged than HA, a factor that may contribute to nonspecific inhibitory effects. To determine the chain length of HA required for interaction with IEs, we tested oligosaccharide fragments of HA ranging from four to sixteen monosaccharide units in length as competitive inhibitors of CS2 IE adhesion. The minimum length of fragment causing substantial inhibition of adhesion to HA was a dodecamer (12 monosaccharide units; Fig 2c) , providing compelling evidence that the interaction of IEs with HA is not due to nonspecific charge effects, but to a specific receptor-ligand interaction. Adhesion to CSA was not inhibited substantially by the HA oligosaccharide fragments.
The variability in the level of adhesion to HA and CSA of the clinical isolates, which may consist of mixed parasite populations, indicates that adhesion is mediated by separate parasite ligands or binding sites. The adhesion of the HA-selected laboratory isolates indicates IEs can co-express ligands for HA and CSA, represented either by separate adhesive molecules or by different sites on the one molecule. However, this does not always occur in vivo, as many clinical isolates were found to bind to one receptor with little or no adhesion to the other. The presence of separate binding sites for HA and CSA is supported by additional experimental findings. Cleavage of CS2 IE surface proteins by treatment with 1 µg/ml trypsin reduced binding to HA by more than 90% (Fig. 2d) , whereas adhesion to CSA was not substantially affected, even at a concentration 1,000-fold higher, as has been reported 11 . The different effects of trypsin on adhesion of IEs has been found with isolates that bind both CD36 and ICAM-1, activities thought to be mediated by different domains of the same adhesive molecule 12 . Furthermore, although there was some cross-inhibitory effect on binding to the two receptors using HA and CSA polysaccharides, this effect was clarified by the finding that HA oligosaccharide fragments effectively inhibited adhesion to immobilized HA with little or no effect on binding to CSA (Fig. 2c) .
Results from studies using flow-based assays, modeling conditions that exist in vivo 13 , support a role for adhesion to HA in the placenta, and validate the results from static adhesion assays. High levels of adhesion from flow (Fig. 3a) 15 , adhesion was greatly reduced, on average by 89.4 ± 2.4%. There was no binding at a wall shear stress of 0.2 Pa. Most (>90%) of erythrocytes that adhered were 'parasitized', and remained stationary, rather than rolling. The stress required to detach 50% of adherent cells was 0.38 ± 0.13 Pa (mean ± s.e.m.).
Even at stresses higher than the range predicted for capillaries and post-capillary venules, a proportion of IEs resisted detachment (Fig. 3b) indicating that binding of substantial numbers of IEs can be maintained, provided conditions favor initial attachment. A particular subset of IEs that bind with lower affinity may preferentially adhere in the placenta rather than other vascular beds in which wall shear stresses are likely to be higher.
The identification of HA as a receptor for adhesion of P. falciparum-infected erythrocytes from the placenta has considerable implications for the understanding of adverse events at the fetal-maternal interface, indicating that parasite sequestration may subvert the proposed fetal-protective role of HA on syncytiotrophoblasts. The results challenge the existing paradigm that sequestration in the placenta is mediated solely by adhesion to CSA, as has been proposed in a report showing that all placental isolates demonstrate some binding to CSA (ref. 9). Instead, our findings indicate that adhesion to HA and CSA is involved in the process leading to the accumulation of IEs in the placenta. An ability to express different ligands for adhesion in the placenta would convey a survival advantage for P. falciparum by increasing the likelihood of sequestration and thus avoiding splenic clearance from the circulation, even in the face of possible host responses targeting one adhesive interaction. In the case of IEs with multiple receptor specificities, HA may be the receptor of initial attachment of IEs, as it has a much higher molecular weight than CSA (approximately 50 kDa) or its proteoglycan thrombomodulin, and may therefore extend further from the surface of the syncytiotrophoblast layer. Furthermore, the presence of at least two receptors for parasite adhesion may augment sequestration through synergy, as has been demonstrated with co-expression of CD36 and ICAM-1 on endothelial cells 16 , or allow sequestration where only one receptor is present. Such factors may favor the selection of particular parasite variants able to bind both receptors. Elements other than adhesion, such as placental immune function 17 , may influence susceptibility to infection with P. falciparum, but parasite adhesion is an essential determinant that could be addressed therapeutically. Approaches to the possible development of new adhesion-blocking therapies or vaccines may need to target both adhesive interactions to be effective.
Methods
P. falciparum culture and collection. P. falciparum was cultured in vitro as described 10 . Parasite line E8B (FAF-EA8) was derived from a clone of Brazilian P. falciparum isolate ItG2F6 as described 18 , and CS2 was generated by selection for adhesion to Chinese hamster ovary cells five times, followed by two cycles of selection to immobilized purified CSA (ref. 11). Isolate 3D7 was originally provided by D. Walliker. Clinical P. falciparum isolates were obtained from pregnant women attending the Labour Ward or Antenatal Clinic of the Queen Elizabeth Central Hospital, Blantyre, Malawi, and from children who either presented to outpatient clinics with uncomplicated malaria or were admitted with severe malaria at the same hospital. Informed consent was obtained in all cases. Peripheral blood was collected in tubes containing lithium heparin anticoagulant, centrifuged to remove plasma and buffy coat, washed three times in phosphatebuffered saline(PBS), pH 7.4, then cultured in vitro. P. falciparum-infected erythrocytes were collected from freshly delivered infected placentae by gentle washing of tissue sections in PBS with 50 mM EDTA on a tube roller, as described 10 . All aspects of the study received ethical approval from the College of Medicine Research Committee of The University of Malawi, and the Ethics Committee of The Walter and Eliza Hall Institute of Medical Research.
Cytoadherence assays. The following chemicals were used in cytoadherence assays (all glycosaminoglycan and polysulfated sugars were obtained from Sigma): hyaluronic acid from bovine vitreous humor or human umbilical vein (potassium salt); chondroitin sulfate A from bovine trachea or porcine rib; CSA covalently linked to phosphatidylethanolamine 11 ; CD36 (a gift from M. Berndt, Baker Medical Research Institute, Melbourne, Australia); soluble ICAM-1 from transfected Chinese hamster ovarian cells (a gift from A. Boyd, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia); chondroitin sulfate C from shark cartilage; heparan sulfate from bovine kidney; heparin from porcine intestinal mucosa; colominic acid (a sialic acid polymer); chondroitin sulfate B from intestinal mucosa; fucoidan sulfate; dextran sulfate with an average molecular weight of 500 kDa; and pentosan polysulfate.
Assays used P. falciparum trophozoite-infected erythrocytes as described 10, 19 . Receptors were adsorbed for 24 h at 4 °C onto plastic Petri dishes (Falcon 1058; Becton Dickinson, Lincoln Park, New Jersey). In preliminary experiments, we found that HA derived from both bovine vitreous humor (molecular weight, about 250 kDa) and human umbilical vein (molecular weight, about 750 kDa) could support high levels of adhesion, which was maximum at concentrations of 50 µg/ml or 10 µg/ml of each, respectively, when coated on plastic surfaces. Before the assay, plates were blocked with 1% bovine serum albumin in PBS. Subsequently, immobilized receptors spots were overlaid with parasite suspensions, and adhesion was allowed to occur for 30 min at 37 °C. Unbound cells were removed by gentle washing with RPMI-HEPES, pH 6.8, before bound cells were fixed with glutaraldehyde, stained with Giemsa stain, and counted using light microscopy. Laboratory isolates were tested at a parasitemia of 5-10% and 2-5% hematocrit, suspended in RPMI-HEPES, pH 6.8, with 10% 'pooled' human serum (group O). Clinical isolates were tested for adhesion to HA, CSA and CD36 at 1% parasitemia or higher and 5% hematocrit, suspended in RPMI-HEPES, pH 6.8, containing 0.5% bovine serum albumin. Isolates obtained from peripheral blood were cultured for up to 24 h until mature trophozoite forms predominated. Placental isolates typically showed mostly mature forms at the time of collection and could be tested directly for adhesion. In some cases, the parasitemia of clinical isolates was enriched by passage over Percoll gradients 20 . For these, preparations were tested for adhesion at a hematocrit of 2.5%. Glycosaminoglycans were tested at varying concentrations for inhibition of IE adhesion to purified receptors by prior incubation with IE suspensions for 5 min before adhesion assays. Selection for high-level adhesion to HA was made, using a modification of a published procedure 18 , by repeated rounds of adhesion of IEs to immobilized HA, followed by culture of adherent cells.
Preparation of HA oligosaccharide fragments. HA from bovine vitreous humor was partially depolymerized by controlled digestion at 37 °C for 20 h with testicular hyaluronidase 21 (from bovine testes; Sigma) in 0.1 M sodium acetate buffer, pH 5.0, containing 0.15 M NaCl. The extent of digestion was checked for a even distribution of the oligosacchride fragments of different sizes by fast protein liquid chromagraphy on a Superdex 75 column eluted by 0.2 M ammonium acetate at 15 ml/h. The digestion mixture was fractionated by gel filtration chromatography on a Bio-Gel P-6 column (1.6 × 90 cm) after being desalted by Sephadex G10. Bio-Gel P-6 fractions were desalted before quantitation by carbazole assay 22 and analysis by negative-ion liquid secondary ion mass spectrometry 23 to confirm the size of the fragments. Oligosaccharide fragments were tested for inhibition of adhesion at a concentration of 200µg/ml by incubation for 20 min at 37 °C with parasite suspensions, before adhesion assays were done.
Enzymatic digestion of glycosaminoglycans and protease treatment of IEs. HA and CSA immobilized on Petri dishes were treated with 10 µg/ml testicular hyaluronidase in PBS, pH 7.2, for 45 min at 37 °C; 0.025-0.5 units/ml chondroitinase ABC in Tris HCl, pH 8.6, for 10-30 min at 37 °C; 0.5 units/ml heparinase in PBS or without enzyme (control) before adhesion of IEs was tested. Enzymes were obtained from Sigma.
For trypsin digestion of IE surface proteins, parasite cultures were washed three times in PBS, pH 7.2, before being incubated for 15 min at 21 °C with various concentrations of trypsin (TPCK-treated; Worthington Biomedical, Lakewood, New Jersey) in PBS. Control samples were incubated with 100 µg/ml trypsin plus 1 mg/ml soybean trypsin inhibitor. Digestion was then stopped by the addition of 1 mg/ml soybean trypsin inhibitor (Worthington Biomedical, Lakewood, New Jersey) for 5 min, and IEs were washed three times in culture medium containing 10% human serum. The treated IE suspensions were then tested for adhesion to receptors as described above.
Flow-based adhesion assays. Adhesion of P. falciparum-infected erythrocytes to HA was visualized and quantified in flat, rectangular, glass microcapillary tubes ('microslides') connected to a flow control system and mounted on the stage of an inverted phase-contrast light microscope, as described 13, 24 . Microslides were first washed with nitric acid and coated with 5 mg/ml poly-L-lysine, then coated overnight at 4°C with 100 µg/ml HA (from human umbilical vein) in PBS. Microslides were blocked with 1% bovine serum albumin in PBS before the assay. Parasite cultures containing 1.5 × 10 8 erythrocytes/ml at 3-8% parasitemia (mature trophozoite stage), were suspended in RPMI-HEPES medium containing 1% Albumax, pH 7.2, and 'flowed through' microslides at wall shear stresses of 0.05, 0.1 or 0.2 Pa for 5 min, followed by cell-free adhesion medium for 5 min to remove nonadherent cells. Adherent cells were then counted microscopically, and scores were standardized to number of bound IEs per mm 2 per 1 × 10 7 IEs perfused. In separate assays, IEs were allowed to adhere at 0.05 Pa as described above, and then exposed to 'step-wise' increases in wall shear stress (each 5 min in duration) from 0.05 to 4.0 Pa. The numbers of IEs remaining adherent at each level of stress were counted microscopically.
